[ 1 ] Goldenberg RR, Campbell CJ, Bonfiglio M. Giant-cell tumor of bone. An analysis of two hundred and eighteen cases[J]. J Bone Joint Surg Am, 1970, 52(4): 619-664.
[2]
[ 2 ] Campanacci M, Baldini N, Boriani S, et al. Giant-cell tumor of bone[J]. J Bone Joint Surg Am, 1987, 69(1): 106-114.
[3]
[ 3 ] Turcotte RE, Wunder JS, Isler MH, et al. Giant cell tumor of long bone: a Canadian Sarcoma Group study[J]. Clin Orthop Relat Res, 2002, 397(397): 248-258.
[4]
[ 4 ] Trieb K, Bitzan P, Lang S, et al. Recurrence of curetted and bone-grafted giant-cell tumours with and without adjuvant phenol therapy[J]. Eur J Surg Oncol, 2001, 27(2): 200-202.
[5]
[ 5 ] Werner M. Giant cell tumour of bone: morphological, biological and histogenetical aspects[J]. Int Orthop, 2006, 30(6): 484-489.
[6]
[ 6 ] Thomas DM, Skubitz KM. Giant cell tumour of bone[J]. Curr Opin Oncol, 2009, 21(4): 338-344.
[7]
[ 7 ] Dickson BC, Li SQ, Wunder JS, et al. Giant cell tumor of bone express p63[J]. Mod Pathol, 2008, 21(4): 369-375.
[8]
[ 8 ] Jeys LM, Suneja R, Chami G, et al. Impending fractures in giant cell tumours of the distal femur: incidence and outcome[J]. Int Orthop, 2006, 30(2): 135-138.
[9]
[ 9 ] Blackley HR, Wunder JS, Davis AM, et al. Treatment of giant-cell tumors of long bones with curettage and bone-grafting[J]. J Bone Joint Surg Am, 1999, 81(6): 811-820.
[10]
Deheshi BM, Jaffer SN, Griffin AM, et al. Joint salvage for pathologic fracture of giant cell tumor of the lower extremity[J]. Clin Orthop Relat Res, 2007, 459(6): 96-104.
[11]
Mcdonald DJ, Sim FH, Mcleod RA, et al. Giant-cell tumor of bone[J]. J Bone Joint Surg Am, 1986, 68(2): 235-242.
[12]
O’donnell RJ, Springfield DS, Motwani HK, et al. Recurrence of giant-cell tumors of the long bones after curettage and packing with cement[J]. J Bone Joint Surg Am, 1994, 76(12): 1827-1833.
[13]
Dreinh？fer KE, Rydholm A, Bauer HC, et al. Giant-cell tumours with fracture at diagnosis. Curettage and acrylic cementing in ten cases[J]. J Bone Joint Surg Br, 1995, 77(2): 189-193.
[14]
Chanchairujira K, Jiranantanakorn T, Phimolsarnti R, et al. Factors of local recurrence of giant cell tumor of long bone after treatment: plain radiographs, pathology and surgical procedures[J]. J Med Assoc Thai, 2011, 94(10): 1230-1237.
[15]
Amanatullah DF, Clark TR, Lopez MJ, et al. Giant cell tumor of bone[J]. Orthopedics, 2014, 37(2): 112-120.
[16]
Enneking WF, Dunham W, Gebhardt MC, et al. A system for the functional evaluation of reconstructive procedures after surgical treatment of tumors of the musculoskeletal system[J]. Clin Orthop Relat Res, 1993(286): 241-246.
[17]
Gitelis S, Mallin BA, Piasecki P, et al. Intralesional excision compared with en bloc resection for giant-cell tumors of bone[J]. J Bone Joint Surg Am, 1993, 75(11): 1648-1655.
[18]
Oda Y, Miura H, Tsuneyoshi M, et al. Giant cell tumor of bone: oncological and functional results of long-term follow-up[J]. Jpn J Clin Oncol, 1998, 28(5): 323-328.
[19]
Saikia KC, Bhattacharyya TD, Bhuyan SK, et al. Local recurrences after curettage and cementing in long bone giant cell tumor[J]. Indian J Orthop, 2011, 45(2): 168-173.
[20]
Kostenuik PJ, Nguyen HQ, Mccabe J, et al. Denosumab, a fully human monoclonal antibody to RANKL, inhibits bone resorption and increases BMD in knock-in mice that Express chimeric (murine/human) RANKL[J]. J Bone Miner Res, 2009, 24(2): 182-195.
[21]
Thomas D, Henshaw R, Skubitz K, et al. Denosumab in patients with giant-cell tumour of bone: an open-label, phase 2 study[J]. Lancet Oncol, 2010, 11(3): 275-280.
[22]
Errani C, Ruggieri P, Asenzio MA, et al. Giant cell tumor of the extremity: a review of 349 cases from a single institution[J]. Cancer Treat Rev, 2010, 36(1): 1-7.
[23]
Ghert MA, Rizzo M, Harrelson JM, et al. Giant-cell tumor of the appendicular skeleton[J]. Clin Orthop Relat Res, 2002, 400(40): 201-210.
[24]
Prosser GH, Baloch KG, Tillman RM, et al. Does curettage without adjuvant therapy provide low recurrence rates in giant-cell tumors of bone[J]. Clin Orthop Relat Res, 2005, 435(435): 211-218.
[25]
Tuli SM, Varma BP, Srivastava TP. Giant-cell tumour of bone[J]. Int Orthop, 1978, 2(3): 207-214.
[26]
Klenke FM, Wenger DE, Inwards CY, et al. Giant cell tumor of bone: risk factors for recurrence[J]. Clin Orthop Relat Res, 2011, 469(2): 591-599.
[27]
Arbeitsgemeinschaft Knochentumoren, Becker WT, Dohle J, et al. Local recurrence of giant cell tumor of bone after intralesional treatment with and without adjuvant therapy[J]. J Bone Joint Surg Am, 2008, 90(5): 1060-1067.
[28]
Balke M, Schremper L, Gebert C, et al. Giant cell tumor of bone: treatment and outcome of 214 cases[J]. J Cancer Res Clin Oncol, 2008, 134(9): 969-978.
[29]
Kivioja AH, Blomqvist C, Hietaniemi K, et al. Cement is recommended in intralesional surgery of giant cell tumors: a Scandinavian Sarcoma Group study of 294 patients followed for a median time of 5 years[J]. Acta Orthop, 2008, 79(1): 86-93.
[30]
van der Heijden L, Dijkstra PD, Campanacci DA, et al. Giant cell tumor with pathologic fracture: should we curette or resect[J]. Clin Orthop Relat Res, 2013, 471(3): 820-829.
[31]
Biau D, Faure F, Katsahian S, et al. Survival of total knee replacement with a megaprosthesis after bone tumor resection[J]. J Bone Joint Surg Am, 2006, 88(6): 1285-1293.
[32]
Kinkel S, Lehner B, Kleinhans JA, et al. Medium to long-term results after reconstruction of bone defects at the knee with tumor endoprostheses[J]. J Surg Oncol, 2010, 101(2): 166-169.
[33]
Niu X, Zhang Q, Hao L, et al. Giant cell tumor of the extremity: retrospective analysis of 621 Chinese patients from one institution[J]. J Bone Joint Surg Am, 2012, 94(5): 461-467.
[34]
Henderson ER, Groundland JS, Pala E, et al. Failure mode classification for tumor endoprostheses: retrospective review of five institutions and a literature review[J]. J Bone Joint Surg Am, 2011, 93(5): 418-429.
[35]
Jeys LM, Grimer RJ, Carter SR, et al. Periprosthetic infection in patients treated for an orthopaedic oncological condition[J]. J Bone Joint Surg Am, 2005, 87(4): 842-849.
[36]
Shehadeh A, Noveau J, Malawer M, et al. Late complications and survival of endoprosthetic reconstruction after resection of bone tumors[J]. Clin Orthop Relat Res, 2010, 468(11): 2885-2895.
